Clinical Trials Logo

Solid Malignancies clinical trials

View clinical trials related to Solid Malignancies.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT00751894 Not yet recruiting - Solid Malignancies Clinical Trials

Pegfilgrastim for Stem Cell Mobilization in Children (Meg-5)

MEG-5
Start date: n/a
Phase: Phase 2
Study type: Interventional

Hypothesis : pegfilgrastim at 200 µg/kg between 12 and 18 days after previous chemotherapy provides an efficient stem cell mobilization in children with malignancies Design: phase 2 study. Judgment criterion: percentage of children achieving at least 5x10e6 CD34 cells with a standard apheresis (less than 3 blood volume processed